相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Symptoms, Psychosocial Factors, and Health-Related Quality of Life in Patients With Neuroendocrine Tumors An Integrative Review
Trude Haugland et al.
CANCER NURSING (2019)
Observational Study to Assess Quality of Life in Patients with Pancreatic Neuroendocrine Tumors Receiving Treatment with Everolimus: The OBLIQUE Study (UK Phase IV Trial)
John K. Ramage et al.
NEUROENDOCRINOLOGY (2019)
Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial
Jonathan Strosberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Marianne E. Pavel et al.
LANCET ONCOLOGY (2017)
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
J. Strosberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
Arvind Dasari et al.
JAMA ONCOLOGY (2017)
Patient-reported Symptom Experiences in Patients With Carcinoid Syndrome After Participation in a Study of Telotristat Etiprate: A Qualitative Interview Approach
Heather L. Gelhorn et al.
CLINICAL THERAPEUTICS (2016)
Association between general self-efficacy, social support, cancer-related stress and physical health-related quality of life: a path model study in patients with neuroendocrine tumors
Trude Haugland et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2016)
ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors
M. Falconi et al.
NEUROENDOCRINOLOGY (2016)
Patient-Reported Outcomes and Quality of Life with Sunitinib Versus Placebo for Pancreatic Neuroendocrine Tumors: Results From an International Phase III Trial
Aaron Vinik et al.
TARGETED ONCOLOGY (2016)
Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors
P. Jimenez-Fonseca et al.
CANCER AND METASTASIS REVIEWS (2015)
Riding a roller coaster: narrative typologies of patients with neuroendocrine tumors
Alessia Miconi et al.
JOURNAL OF MULTIDISCIPLINARY HEALTHCARE (2015)
Hallmarks of gastrointestinal neuroendocrine tumours: implications for treatment
Annemiek Walenkamp et al.
ENDOCRINE-RELATED CANCER (2014)
Overcoming barriers to the implementation of patient-reported outcomes in cancer clinical trials: the PROMOTION Registry
Fabio Efficace et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2014)
Recommended Patient-Reported Core Set of Symptoms to Measure in Adult Cancer Treatment Trials
Bryce B. Reeve et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
Martyn E. Caplin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Validation of the EORTC QLQ-GINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumours
G. Yadegarfar et al.
BRITISH JOURNAL OF CANCER (2013)
Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards
Michael Brundage et al.
QUALITY OF LIFE RESEARCH (2013)
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
John K. Ramage et al.
GUT (2012)
Comparison of Health-Related Quality of Life in Patients With Neuroendocrine Tumors With Quality of Life in the General US Population
Jennifer L. Beaumont et al.
PANCREAS (2012)
Long-term results of treatment of malignant carcinoid syndrome with prolonged release Lanreotide (Somatuline Autogel)
M. S. Khan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Quality of Life in 265 Patients with Gastroenteropancreatic or Bronchial Neuroendocrine Tumors Treated with [177Lu-DOTA0,Tyr3]Octreotate
Saima Khan et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors.
Eric Raymond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
James C. Yao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
Anja Rinke et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Health related quality of life and psychosocial function among patients with carcinoid tumours.: A longitudinal, prospective, and comparative study
Camilla Frojd et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2007)
Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study
Ethan Basch et al.
LANCET ONCOLOGY (2006)
Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance
HEALTH AND QUALITY OF LIFE OUTCOMES (2006)
Development of a disease-specific quality of life questionnaire module for patients with gastrointestinal neuroendocrine tumours
AHG Davies et al.
EUROPEAN JOURNAL OF CANCER (2006)
Octreotide versus octreotide plus interferon-alpha in endocrine gastroenteropancreatic tumors:: A randomized trial
R Arnold et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
Interferon and meta-iodobenzylguanidin combinations in the treatment of metastatic carcinoid tumours
JM Zuetenhorst et al.
ENDOCRINE-RELATED CANCER (2004)
The diagnosis and medical management of advanced neuroendocrine tumors
GA Kaltsas et al.
ENDOCRINE REVIEWS (2004)
Use of differential item functioning analysis to assess the equivalence of translations of a questionnaire
MA Petersen et al.
QUALITY OF LIFE RESEARCH (2003)
Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate
DJ Kwekkeboom et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
分享论文
